Glycan analysis of therapeutic glycoproteins - Wikidata - awgldk - TriplyDB

Glycan analysis of therapeutic glycoproteins

Glycan analysis of therapeutic glycoproteins

http://www.wikidata.org/entity/Q28082842

about

Avian embryos and related cell lines: A convenient platform for recombinant proteins and vaccine production.A standardized method for lectin microarray-based tissue glycome mapping Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.Genetic mutation analysis at early stages of cell line development using next generation sequencing.Application of Lectin Array Technology for Biobetter Characterization: Its Correlation with FcγRIII Binding and ADCC.Alga-Made Anti-Hepatitis B Antibody Binds to Human Fcγ Receptors.CHO-Omics Review: The Impact of Current and Emerging Technologies on Chinese Hamster Ovary Based Bioproduction.The sweet spot for biologics: recent advances in characterization of biotherapeutic glycoproteins.Platforms for Recombinant Therapeutic Glycoprotein Production.Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses.

P2860

Q30234979-09C104CC-1061-434A-8A43-4C47C6F8DB0E Q36297916-E6DA6BB8-D52F-4AD4-AA83-029CE3C1B9C9 Q38694148-D5F844C4-3211-493D-A3AA-256CEC284A76 Q38784055-C087656F-6C4B-45BE-833C-9B4B9EBFBE7E Q42293231-CDDEB4F6-9D18-462F-9F11-36BD2D0970FD Q47341896-6D91CB3D-2A30-4FDD-B692-CC2547872F29 Q47408673-D97C756D-1C2E-4362-A5DF-18FB1C86DAEF Q47410418-6BB18C2E-EFBF-49BF-A66A-7B65E39E785A Q47786965-33F9BE59-4136-47A7-823A-37854AFCBB8E Q52684751-41A75AE2-AD84-442B-B996-DBD25A460B29

P2860

Glycan analysis of therapeutic glycoproteins

http://www.wikidata.org/entity/Q28082842

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Glycan analysis of therapeutic glycoproteins

@ast

Glycan analysis of therapeutic glycoproteins

@en

Glycan analysis of therapeutic glycoproteins

@nl

type

label

Glycan analysis of therapeutic glycoproteins

@ast

Glycan analysis of therapeutic glycoproteins

@en

Glycan analysis of therapeutic glycoproteins

@nl

prefLabel

Glycan analysis of therapeutic glycoproteins

@ast

Glycan analysis of therapeutic glycoproteins

@en

Glycan analysis of therapeutic glycoproteins

@nl

P1433

Q28082842-42965508-FFD4-4D21-84E3-7266BBCD6E7D

P1476

Q28082842-BB9156EA-882B-43CD-9E4F-B1D4AB3B571E

P2093

Q28082842-1259F0AF-1DAD-47B6-89BD-01458E39B61D

Q28082842-1320DED3-30A1-4F71-B448-596AE0895FC2

Q28082842-AF5DC151-CAFA-4719-A190-1FD2C9222B56

P275

Q28082842-12D52174-F6AD-4F41-906D-3120B79017CC

P2860

Q28082842-0442BC26-6E81-464C-B32E-2F746D6E4AA0

Q28082842-074A6B2C-C066-4C47-97D0-9750142A559E

Q28082842-0B0B886C-829F-4D2F-90B8-6F6E62F21E6B

Q28082842-0C4E7203-E4F4-44A5-A578-8A598381706E

Q28082842-0C7E1E01-E649-4738-AFFC-E7461CD075AE

Q28082842-0D1708FE-28DB-4815-ACE8-B85DAF1F4D5D

Q28082842-0D5DFF31-6F24-4EFD-ADFA-17A3A269804D

Q28082842-0DDF4A63-8225-431B-8F43-E866DBFBBEA2

Q28082842-11C0468E-1EE4-4DEB-83A8-082E6A0CCC7F

Q28082842-12002F8C-4C8A-4B7E-A052-A14FDE6CC8BD

P304

Q28082842-17BE8F86-64BB-45D4-86D7-C019643643FE

P31

Q28082842-146D3BF7-B639-4012-B0FE-D4B8291C92BA

Q28082842-ABEE0C03-7F78-42B0-B85F-7267123F5A94

P356

Q28082842-1E748AE5-F877-4EC7-8766-0C77A8B8A815

P407

Q28082842-0CDD6470-758E-4283-B43C-9565354CC015

P433

Q28082842-64C9B243-F9B2-4230-A442-58F79F12FE49

P478

Q28082842-B764FD31-1AE2-42A9-BEDC-9C164CE15C79

P577

Q28082842-78650720-C059-4832-B113-47535823913F

Q28082842-83CFB5E9-97FB-47E3-A697-53F29972B19A

P5875

Q28082842-75343DA4-5A5D-4AF6-8366-54F86BFAB959

P698

Q28082842-9EFBDA6B-5A0A-4646-8284-6CCDA2CCD0C4

P921

Q28082842-2061CD47-5C0A-4C87-A3D5-BB5F49320D4A

Q28082842-374E9921-1482-4A96-A5B5-1418E06EBFB2

Q28082842-7558DB01-8306-4500-9859-B233D414E84D

Q28082842-8A418E77-0555-4F5E-9BCF-F8DD1A317BE1

Q28082842-D5DB5D98-BF55-4023-A9AB-ED236DB8CA04

P932

Q28082842-8F72FB22-DA4E-44D1-A789-716F4BDFBBA3

P356

19420862.2015.1117719

P1433

Monoclonal Antibodies

P1476

Glycan analysis of therapeutic glycoproteins

@en

P2093

Baolin Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Shen Luo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

Fc glycans of therapeutic antibodies as critical quality attributes

Translating basic mechanisms of IgG effector activity into next generation cancer therapies

Assembly of asparagine-linked oligosaccharides

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

Structure and function of the cell surface (tethered) mucins

Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins.

Analytical lessons learned from selected therapeutic protein drug comparability studies.

Comprehensive assessment of N-glycans derived from a murine monoclonal antibody: a case for multimethodological approach.

Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection.

P304

205-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2015.1117719

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284550680

http://www.w3.org/2001/XMLSchema#string

P698

26599345

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

monoclonal antibody

P932

4966609

http://www.w3.org/2001/XMLSchema#string